Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Drucker

Showing results (41-50 of 313) with videos related to

Pageof 32
Sort By:
Lancet (London, England)|May 27, 2008
Intensive insulin therapy in newly diagnosed type 2 diabetesRavi Retnakaran, Daniel J Drucker
Regulatory Peptides|March 23, 2005
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout miceTanya Hansotia, Daniel J Drucker
Endocrinology|October 18, 2007
Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time?Irene Hadjiyanni, Daniel J Drucker
Endocrine Reviews|October 13, 2016
Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical RelevanceGemma Pujadas, Daniel J Drucker
Molecular Endocrinology (Baltimore, Md.)|September 28, 2002
Pax-2 activates the proglucagon gene promoter but is not essential for proglucagon gene expression or development of proglucagon-producing cell lineages in the murine pancreas or intestineGrace Flock, Daniel J Drucker
American Journal of Physiology. Endocrinology and Metabolism|January 1, 2009
Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetesSafina Ali, Daniel J Drucker
Annual Review of Medicine|January 18, 2006
Therapeutic approaches to preserve islet mass in type 2 diabetesLaurie L Baggio, Daniel J Drucker
The Journal of Nutrition|November 11, 2003
Dual regulation of cell proliferation and survival via activation of glucagon-like peptide-2 receptor signalingJennifer L Estall, Daniel J Drucker
Endocrinology|November 30, 2019
Proglucagon-Derived Peptides, Glucose-Dependent Insulinotropic Polypeptide, and Dipeptidyl Peptidase-4-Mechanisms of Action in Adipose TissueJacqueline L Beaudry, Daniel J Drucker
Annual Review of Nutrition|April 11, 2006
Glucagon-like Peptide-2Jennifer L Estall, Daniel J Drucker
Pageof 32

Showing results (41-50 of 313) with videos related to

Sort By:
Pageof 32
Lancet (London, England)|May 27, 2008
Intensive insulin therapy in newly diagnosed type 2 diabetesRavi Retnakaran, Daniel J Drucker
Regulatory Peptides|March 23, 2005
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout miceTanya Hansotia, Daniel J Drucker
Endocrinology|October 18, 2007
Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time?Irene Hadjiyanni, Daniel J Drucker
Endocrine Reviews|October 13, 2016
Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical RelevanceGemma Pujadas, Daniel J Drucker
Molecular Endocrinology (Baltimore, Md.)|September 28, 2002
Pax-2 activates the proglucagon gene promoter but is not essential for proglucagon gene expression or development of proglucagon-producing cell lineages in the murine pancreas or intestineGrace Flock, Daniel J Drucker
American Journal of Physiology. Endocrinology and Metabolism|January 1, 2009
Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetesSafina Ali, Daniel J Drucker
Annual Review of Medicine|January 18, 2006
Therapeutic approaches to preserve islet mass in type 2 diabetesLaurie L Baggio, Daniel J Drucker
The Journal of Nutrition|November 11, 2003
Dual regulation of cell proliferation and survival via activation of glucagon-like peptide-2 receptor signalingJennifer L Estall, Daniel J Drucker
Endocrinology|November 30, 2019
Proglucagon-Derived Peptides, Glucose-Dependent Insulinotropic Polypeptide, and Dipeptidyl Peptidase-4-Mechanisms of Action in Adipose TissueJacqueline L Beaudry, Daniel J Drucker
Annual Review of Nutrition|April 11, 2006
Glucagon-like Peptide-2Jennifer L Estall, Daniel J Drucker
Pageof 32